Opendata, web and dolomites

Nanozymes POC

Nanozymes POC

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "Nanozymes POC" data sheet

The following table provides information about the project.

Coordinator
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE 

Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ
website: http://www.imperial.ac.uk/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 148˙646 €
 EC max contribution 148˙646 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-PoC
 Funding Scheme ERC-POC
 Starting year 2018
 Duration (year-month-day) from 2018-07-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE UK (LONDON) coordinator 148˙646.00

Map

 Project objective

'Point-of-care biosensing technologies often suffer from low sensitivity, specificity, affordability and simplicity. Within 'Nanozymes POC' we are exploiting a lateral flow immunoassay point-of-care technology supported from the ERC award 'Naturale CG'. Our paper-based point-of-care device comprises a lateral flow immunosorbent assay showing a sensitivity of 100pg/mL p24 detection and a 100-fold improvement in sensitivity following a catalytic development step involving platinum core-shell nanoparticles (PtNCs) called “nanozymes”. This technology detects p24 in spiked plasma pool at concentrations as low as 1 pg/mL and has enormous potential for detection of HIV at earlier stages soon after infection, amenable for use in low- and middle-income countries. Within this award, we are optimising the components and their stability and performing tests using clinically relevant samples and in the field. We are also exploring the expansion of this platform technology for its potential in detecting biomarkers for cancer. The commercial strategy performed within Nanozymes POC will support its translation potential, targeting that patients can receive more timely access to treatment options and improve their quality of life.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NANOZYMES POC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NANOZYMES POC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

PROTECHT (2020)

Providing RObust high TECHnology Tags based on linear carbon nanostructures

Read More  

MuFLOART (2018)

Microbiological fluorescence observatory for antibiotic resistance tracking

Read More  

LapIt (2019)

Making AML treatment a clinical reality: A novel anti-IL7 receptor antibody to deliver Lap to 5LO positive cells

Read More